NCT01090856

Brief Summary

Percutaneous treatment of bifurcation lesion is a complex procedure. After main vessel stent implantation, the side branch became jailed and the carina can be displaced resulting in complete occlusion of this vessel. Re-wiring the side branch in this conditions may result difficult and some times impossible. There is no agreement regarding the need of side branch pre-dilation (before main vessel stent implantation) to reduce these complications. Researchers from European Bifurcation Club have proposed no to pre-dilate the side branch to avoid vessel dissection and difficulties in rewiring the true lumen of the vessel. On the contrary, our group has a good experience in the treatment of bifurcation lesions treated with side branch pre-dilation. Aims: 1.- To determine the efficacy of the side-branch pre-dilation in patients with bifurcations lesions treated with provisional T stenting. 2.- To determine the success rate and incidence of complications in patients with and without side-branch pre-dilation, as well as economic impact in terms of number of used wires.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
420

participants targeted

Target at P75+ for phase_4

Timeline
Completed

Started Feb 2009

Longer than P75 for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2009

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

March 22, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

March 23, 2010

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2012

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2013

Completed
Last Updated

December 5, 2014

Status Verified

May 1, 2013

Enrollment Period

3.8 years

First QC Date

March 22, 2010

Last Update Submit

December 4, 2014

Conditions

Keywords

BifurcationsDrug eluting-stentsProvisional stenting

Outcome Measures

Primary Outcomes (1)

  • Side branch coronary flow after main vessels stent implantation

    Immediately after catheterization procedure

Secondary Outcomes (4)

  • Time required for rewiring of the side branch

    Inmediately after catheterization procedure

  • Number of used wires

    Inmediately after catheterization procedure

  • Levels of markers of myocardial injury (CK and TpI) after the procedure

    Immediately after catheterization procedure

  • Related cardiac events at 9 months

    Immediately after catheterization procedure

Study Arms (2)

No pre-dilation side branch

NO INTERVENTION

Pre-dilation side branch

ACTIVE COMPARATOR
Procedure: Pre-dilation side branch

Interventions

Balloon pre-dilation of the side branch to facilitate the ulterior wire access.

Pre-dilation side branch

Eligibility Criteria

Age30 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with atherosclerotic coronary disease and bifurcation lesions an significant stenosis of the side branch.
  • Main vessels diameter greater than 2.5 mm in diameter at the operator's visual estimate.
  • The side branch should exceed 2.25 mm in diameter at the operator's visual estimate.
  • Patients with damage to the main branch of any length and the side branch lesions smaller than 5 mm in length.
  • Patients with bifurcation lesions fulfilling the following morphologies of the classification of Medina: 1 1 1, 1 0 1, 0 1 1.
  • Treatment of bifurcation lesions with previsional drug eluting stents.
  • Symptoms of stable angina or acute coronary syndrome.

You may not qualify if:

  • Contraindication to drug eluting stent implantation.
  • Cardiogenic shock.
  • Coexistence of other serious systemic diseases.
  • Patients in whom it is impossible to guide placement in the side branch before stent implantation in the main vessel.
  • Patients with bifurcation lesions and side branch less than 2 mm.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Universitario Reina Sofía

Córdoba, Córdoba, 14004, Spain

Location

Related Publications (9)

  • Pan M, Medina A, Suarez de Lezo J, Romero M, Melian F, Pavlovic D, Hernandez E, Segura J, Marrero J, Torres F, et al. Follow-up patency of side branches covered by intracoronary Palmaz-Schatz stent. Am Heart J. 1995 Mar;129(3):436-40. doi: 10.1016/0002-8703(95)90264-3.

    PMID: 7872167BACKGROUND
  • Pan M, Suarez de Lezo J, Medina A, Romero M, Hernandez E, Segura J, Castroviejo JR, Pavlovic D, Melian F, Ramirez A, Castillo JC. Simple and complex stent strategies for bifurcated coronary arterial stenosis involving the side branch origin. Am J Cardiol. 1999 May 1;83(9):1320-5. doi: 10.1016/s0002-9149(99)00093-4.

    PMID: 10235088BACKGROUND
  • Pan M, Suarez de Lezo J, Medina A, Romero M, Segura J, Ramirez A, Pavlovic D, Hernandez E, Ojeda S, Adamuz C. A stepwise strategy for the stent treatment of bifurcated coronary lesions. Catheter Cardiovasc Interv. 2002 Jan;55(1):50-7. doi: 10.1002/ccd.10057.

    PMID: 11793495BACKGROUND
  • Pan M, de Lezo JS, Medina A, Romero M, Segura J, Pavlovic D, Delgado A, Ojeda S, Melian F, Herrador J, Urena I, Burgos L. Rapamycin-eluting stents for the treatment of bifurcated coronary lesions: a randomized comparison of a simple versus complex strategy. Am Heart J. 2004 Nov;148(5):857-64. doi: 10.1016/j.ahj.2004.05.029.

    PMID: 15523318BACKGROUND
  • Pan M, Suarez de Lezo J, Medina A, Romero M, Delgado A, Segura J, Ojeda S, Pavlovic D, Ariza J, Fernandez-Duenas J, Herrador J, Urena I. [Six-month intravascular ultrasound follow-up of coronary bifurcation lesions treated with rapamycin-eluting stents: technical considerations]. Rev Esp Cardiol. 2005 Nov;58(11):1278-86. Spanish.

    PMID: 16324581BACKGROUND
  • de Lezo JS, Medina A, Pan M, Delgado A, Segura J, Pavlovic D, Melian F, Romero M, Burgos L, Hernandez E, Urena I, Herrador J. Rapamycin-eluting stents for the treatment of unprotected left main coronary disease. Am Heart J. 2004 Sep;148(3):481-5. doi: 10.1016/j.ahj.2004.03.011.

    PMID: 15389236BACKGROUND
  • Medina A, Suarez de Lezo J, Pan M. [A new classification of coronary bifurcation lesions]. Rev Esp Cardiol. 2006 Feb;59(2):183. No abstract available. Spanish.

    PMID: 16540043BACKGROUND
  • Pan M, Suarez de Lezo J, Medina A, Romero M, Delgado A, Segura J, Ojeda S, Mazuelos F, Hernandez E, Melian F, Pavlovic D, Esteban F, Herrador J. Drug-eluting stents for the treatment of bifurcation lesions: a randomized comparison between paclitaxel and sirolimus stents. Am Heart J. 2007 Jan;153(1):15.e1-7. doi: 10.1016/j.ahj.2006.10.017.

    PMID: 17174630BACKGROUND
  • Pan M, Medina A, Romero M, Ojeda S, Martin P, Suarez de Lezo J, Segura J, Mazuelos F, Novoa J, Suarez de Lezo J. Assessment of side branch predilation before a provisional T-stent strategy for bifurcation lesions. A randomized trial. Am Heart J. 2014 Sep;168(3):374-80. doi: 10.1016/j.ahj.2014.05.014. Epub 2014 Jun 6.

Study Officials

  • Manuel Pan Alvarez-Osorio, MD

    Hospital Universitario Reina Sofia de Cordoba

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 22, 2010

First Posted

March 23, 2010

Study Start

February 1, 2009

Primary Completion

November 1, 2012

Study Completion

May 1, 2013

Last Updated

December 5, 2014

Record last verified: 2013-05

Locations